Chandra Bhagat Pharma
44.65
-2.35(-5.00%)
Market Cap₹33.72 Cr
PE Ratio11.63
IndustryHealthcare
Company Performance:
1D-5.00%
1M+2.93%
6M+15.97%
1Y-6.98%
5Y0.00%
View Company Insightsright
More news about Chandra Bhagat Pharma
01Apr 26
Chandra Bhagat Pharma Limited Opens New International Office in Dubai, UAE
Chandra Bhagat Pharma Limited has established a new international office in Dubai, UAE, as part of its strategic global expansion plans. The International Business/Representative Office, located in Sharjah Media City, commenced operations on March 31, 2026, with formation number 2645307. The initiative aims to expand the company's global footprint, enhance export opportunities, and strengthen international client relationships. The company has obtained proper regulatory approvals from Sharjah Media City Free Zone Authority and informed BSE Limited in compliance with SEBI listing requirements.
 no imag found
21Jan 26
Chandra Bhagat Pharma Files Corporate Governance Non-Applicability Certificate for Q3 FY26
Chandra Bhagat Pharma Limited filed a certificate with BSE on January 21, 2026, stating corporate governance provisions are not applicable for Q3 FY26 ended December 31, 2025. The exemption is based on the company's SME Exchange listing under SEBI Regulation 15, which provides relief from multiple corporate governance requirements including Regulations 17-27 and specific clauses of Regulation 46 and Schedule V.
 no imag found
13Nov 25
Chandra Bhagat Pharma Reports Half-Year Financial Results for September 2025
Chandra Bhagat Pharma Limited announced its unaudited financial results for the half year ended September 30, 2025. The company reported revenue from operations of ₹2,354.60 lakhs and a profit after tax of ₹44.91 lakhs. The results were approved by the Board of Directors and reviewed by A Y & Company, Chartered Accountants. The company's trading window will reopen 48 hours after the announcement of the financial statement, in compliance with SEBI regulations on insider trading.
 no imag found
Chandra Bhagat Pharma
44.65
-2.35
(-5.00%)
1 Year Returns:-6.98%
Industry Peers
Sun Pharmaceutical
1,874.00
(-0.63%)
Divis Laboratories
9,464.50
(-1.15%)
Torrent Pharmaceuticals
4,948.00
(-0.24%)
Zydus Life Science
1,130.00
(-1.35%)
Cipla
1,372.30
(-0.85%)
Laurus Labs
1,941.30
(-0.29%)
Aurobindo Pharma
1,683.90
(-0.48%)
Lupin
2,104.60
(+0.00%)
Dr Reddys Laboratories
1,145.00
(-0.52%)
Mankind Pharma
2,276.50
(-1.41%)